Furthermore, a study of 39 men aged 50–70 years with low T levels and T2DM treated with metformin monotherapy, randomized to T gel (n = 20) or placebo (n = 19) for 24 weeks, showed that the beneficial effect of T therapy on body composition was not accompanied by improved insulin sensitivity (170). This evidence concerns the gene INS and type 2 diabetes mellitus.